Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 May 16.
Published in final edited form as: Dev Biol. 2007 Nov 12;313(2):603–613. doi: 10.1016/j.ydbio.2007.10.051

Transcriptional Control of Cell-Cycle Quiescence During C. elegans Development

Joseph E Clayton a, Sander JL van den Heuvel b,1, R Mako Saito a,1,*
PMCID: PMC2386670  NIHMSID: NIHMS38750  PMID: 18082681

Abstract

During the development of the C. elegans reproductive system, cells that give rise to the vulva, the vulval precursor cells (VPCs), remain quiescent for two larval stages before resuming cell division in the third larval stage. We have identified several transcriptional regulators that contribute to this temporary cell-cycle arrest. Mutation of lin-1 or lin-31, two downstream targets of the Receptor Tyrosine kinase (RTK)/Ras/MAP kinase cascade that controls VPC cell fate, disrupts the temporary VPC quiescence. We found that the LIN-1/Ets and LIN-31/FoxB transcription factors promote expression of CKI-1, a member of the p27 family of cyclin-dependent kinase inhibitors (CKIs). LIN-1 and LIN-31 promote cki-1/Kip-1 transcription prior to their inhibition through RTK/Ras/MAPK activation. Another mutation identified in the screen defined the mdt-13 TRAP240 Mediator subunit. Further analysis of the multisubunit Mediator complex revealed that a specific subset of its components act in VPC quiescence. These components substantially overlap with the CDK-8 module implicated in transcriptional repression. Taken together, strict control of cell-cycle quiescence during VPC development involves transcriptional induction of CKI-1 and transcriptional regulation through the Mediator complex. These transcriptional regulators represent potential molecular connections between development and the basic cell-cycle machinery.

Keywords: C. elegans, vulval development, cell-cycle quiescence, transcription, foxB, Ets, Mediator, CKI

INTRODUCTION

The development of multicellular organisms involves a precise choreography of numerous aspects of cell division, growth and differentiation. This intercellular coordination is often critically dependent on spatial and temporal control of cell divisions to ensure the co-existence of the appropriate cells. For example, heterochronic gene mutations disrupt the developmental timing of multiple cell lineages in C. elegans (Ambros and Horvitz, 1984). The heterochronic defect perturbs the developmental coordination between presumptive vulval and uterine lineages and results in a deformed adult structure that is unable to lay eggs (Euling and Ambros, 1996). The current study examines the mechanisms used by developmental programs to regulate cell division in order to ensure that the appropriate cell populations are available for vulva organogenesis.

Multiple families of proto-oncogenes and tumor-suppressors are crucial for cell-cycle control during C. elegans development. The core cell-cycle machinery in C. elegans is highly conserved with higher metazoans, albeit with a simplified configuration as many gene families are represented by a single member. For example, cell-cycle entry is regulated by a single cyclin D/Cdk4 complex encoded by the cyd-1 and cdk-4 loci (Boxem and van den Heuvel, 2001; Park and Krause, 1999). The lack of functional redundancy in C. elegans allowed the demonstration that CYD-1/CDK-4 activity promotes G1/S progression by inactivating two partially redundant inhibitory pathways mediated by the sole Retinoblastoma family member, lin-35, and a p27 Cip/Kip cyclin-dependent kinase inhibitor, cki-1 (Boxem and van den Heuvel, 2001). Importantly, the relationship between these pathways appears to be conserved between C. elegans and vertebrates (Park et al., 1999). By analogy with other systems, LIN-35 Rb likely inhibits S-phase by transcriptional repression of S-phase genes (Dyson, 1998) and potentially other mechanisms (Binne et al., 2007), while CKI-1 Cip/Kip directly binds and inhibits the cyclin E/Cdk2 complex (Ekholm and Reed, 2000). In fact, in vivo studies of lin-35 function have identified multiple target genes, including negative regulation of cyclin E (Chi and Reinke, 2006; Grishok and Sharp, 2005; Kirienko and Fay, 2007). However, the mechanisms to integrate developmental signals and yield control of the cell-cycle machinery are not completely understood.

The highly reproducible cell cycles during C. elegans vulva development provide an ideal model system for identifying the mechanisms coordinating cell divisions in living animals ((Sulston and Horvitz, 1977) and Fig. 1A). During the first larval stage (L1), six vulval precursor cells (VPCs) are created which arrest immediately in an extended G1 phase (Euling and Ambros, 1996). The VPCs remain quiescent until the mid-third larval stage (mid-L3) at which time they resume divisions and differentiate. Interestingly, the divisions that create the VPCs in L1 also produce neuroblast siblings that continue through several rounds of cell divisions without delay and ultimately develop as neurons. Thus, the VPCs are selectively targeted for a temporary cell-cycle arrest that is overcome specifically during the L3 stage. We utilized these characteristics of vulva production to study the mechanisms that regulate temporary cell-cycle quiescence during metazoan development.

Fig. 1.

Fig. 1

VPC development provides an attractive system for the study of temporal regulation of cell-cycle entry. (A) Schematic diagram of generalized post-embryonic P lineage. P cells divide mid-L1 to give rise to anterior (Pn.a) and posterior (Pn.p) progeny cells. The posterior progeny of P3 through P8 form the VPCs. Unlike the Pn.a siblings, the VPCs enter a quiescent period until mid-L3. During late L2/early L3 the quiescent VPCs receive a LIN-3-initiated signal that directs cell-fate selection. (B) Wild-type adult hermaphrodite with indicated vulva (arrow). (C) Adult lin-12(gf) hermaphrodite displaying inappropriately induced pseudovulvae (small arrows). Since the pseudovulvae originate from the VPCs (P3.p through P8.p), a maximum of six are observed. (D) lin-12(gf) strains harboring the lag-2(sa37) mutation produce larger broods, are cross-fertile and display generally improved health compared to lin-12(gf) single mutant animals. (E) The seven mutations isolated in the genetic screen for the Elm phenotype.

Prior to the mid-L3 cell divisions, the quiescent VPCs are instructed to choose between the hypodermal (skin) and vulval fates through a series of well-characterized cell-cell interactions that include the RTK/Ras/MAPK, Notch and Wnt signaling cascades (Sternberg, 2005). Induction of VPC pattern formation is initiated during late L2/early L3 by LIN-3, a signal produced by the uterine anchor cell (Hill and Sternberg, 1992). Reception of this EGF-related signal initiates a conserved RTK/Ras/MAPK signaling cascade that includes the let-23 EGF-R (Aroian et al., 1990), let-60 Ras (Han and Sternberg, 1990), lin-45 Raf kinase (Han et al., 1993), and mpk-1 MAP kinase (Lackner and Kim, 1998; Wu and Han, 1994) gene products. Among the targets of the signaling cascade are the transcription factors LIN-1 (Beitel et al., 1995) and LIN-31 (Miller et al., 1993). LIN-3 strongly induces the VPC closest to the anchor cell to execute the 1° vulval cell fate. In contrast, the flanking VPCs adopt the 2° vulval cell fate likely as a result of lin-12-mediated lateral inhibition (Greenwald et al., 1983) and weak induction by LIN-3 (Simske and Kim, 1995), while the remaining VPCs take the 3° or hypodermal cell fate. Interestingly, in synMuv (synthetic multivulva) mutant animals, the surrounding hypodermis can induce adoption of vulval cell fates through ectopic expression of LIN-3 (Cui et al., 2006; Fay and Yochem, 2007). Genetic screens for mutations that enhance or suppress the mutant phenotypes of the RTK/Ras/MAPK pathway identified several transcriptional regulators, including components of the Mediator complex (Singh and Han, 1995). Detailed genetic analyses suggest that the Mediator may regulate expression of the genes targeted by the RTK/Ras/MAPK signaling cascade (Howard and Sundaram, 2002). As the Mediator may act more generally as a regulator of signal-activated transcription, such as TGF-β-dependent transcriptional activation (Kato et al., 2002), further studies are necessary to reveal the molecular basis of the cooperation between intercellular signaling and transcriptional regulation by Mediator complexes.

In this study, we sought genes required for the VPC cell-cycle quiescent period during vulva development to identify the mechanisms regulating developmental control of cell-cycle entry and exit. Our genetic screen took advantage of the ability to easily visualize the progeny of individual VPCs to allow the identification of mutant strains producing excessive VPCs. Seven mutant strains that produced extra VPCs were isolated in the course of several screens. These include mutations of three genes, lin-1, lin-31 and mdt-13, that encode transcriptional regulators required for normal control of VPC cell-cycle arrest during vulval development. Our results indicate that lin-1 and lin-31 control VPC cell-cycle quiescence by promoting the cell-type specific expression of the cyclin-dependent kinase inhibitor, cki-1. Isolation of the C. elegans TRAP240 homolog, mdt-13, led us to examine the components of the Mediator complex. We find evidence for the selective requirement of individual Mediator complex subunits. Collectively, these data illustrate the important contribution of a transcriptional network to regulate cell-cycle quiescence during development.

MATERIALS AND METHODS

Strains

The Caenorhabditis elegans strains were grown as previously described (Brenner, 1974), except where noted. The following wild-type (N2)-derived strains were utilized in this study: FX1238: cdk-8(tm1238) I; MH17: sur-2(ku9) I; MT587: lin-31(n301) bli-2(e768) II; MT2131: lin-31(n1053) II; SV510: lin-31(he136) II; SV327: cdc-14(he118) II; DR103: dpy-10(e128) unc-4(e120) II; SV519: mdt-13(he135) unc-4(e120)/mnC1 II; SP364: mdt-13(mn19) unc-4(e120)/mnC1 II; SP635: mnDf66/mnC1 II; PS3931: ref-1(ok288) II; SD378: mpk-1(ga117)/dpy-17(e164) unc-79(e1068) III; GS589: lin-12(n950) III; him-5(e1490) V; MT1035: lin-12(n137n460) III; MT688: lin-12(n137)/unc-32(e189) III; him-5(e1467) V; JT5205: lin-12(n950) III; lag-2(sa37) V; VT825: dpy-20(e1282) IV; maIs113[dpy-20(+) + cki-1::GFP]; MT1355: lin-1(e1777) IV; dpy-7(e1324) sup-7(st5) X; MT8256: lin-1(n304) IV/nT1 [unc-?(n754)let-?](IV:V) ; MT7949: lin-1(n1761gf) IV; SV325: lin-1(he117) IV; SV332: lin-1(he119) IV; SD551: let-60(ga89ts) IV; MT5748: let-60(n2022) IV/nT1 [unc-?(n754)let-?](IV:V) ; MT2124: let-60(n1046gf) IV; UP604: sos-1(cs41ts) V; MT1821: lin-25(e1446) V/nT1 [unc-?(n754)let-?](IV:V); JN147: gap-2(tm748) X; CB652: dpy-22(e652) X; MT6290: lin-8(n2403) II; lin-36(n766) III; MT8189: lin-15(n765) X; MT465: dpy-5(e61) I; bli-2(e768) II; unc-32(e189) III; MT464: unc-5(e53) IV; dpy-11(e224) V; lon-2(e678) X and the Hawaiian isolate, CB4856

Elm phenotype screen

The genetic screen for cell-cycle regulatory genes was performed using lin-12(gf) mutations to visually mark each VPC as a ventral protrusion (pseudovulva) on the adult. Multiple lin-12(gf) strains (Table 1) were subjected to the following general protocol: new mutations were induced using ethylmethanesulfonate (EMS) (Brenner, 1974) or TMP/UV (Yandell et al., 1994), 1-10 F1 hermaphrodites were transferred to new plates, F2 progeny were screened using a dissection stereoscope for the production of supernumerary (greater than 6) pseudovulvae. Further classification of defects was achieved by VPC analysis, described below.

Table 1.

Summary of Elm phenotype screen

version genotype mutagen n1 isolated mutations
1 lin-12(n950) EMS 2,758 cdc-14(he118), lin-1(he119)
2 lin-12(n137n460) EMS 2,900
3 lin-12(n137n460) TMP/UV 10,480 lin-1(he117)
4 lin-12(n137n460); gaIs40 EMS 6,550
5 lin-12(n950); lag-2(sa37) EMS 10,296 mdt-13(he135), lin-31(he136), ref(he137), he138
1

number of haploid genomes screened

VPC analysis

Following the isolation of Elm strains, a secondary screen was used to identify elm mutations that specifically disrupted control of cell-cycle quiescence. Eggs were obtained from gravid hermaphrodites using the standard hypochlorite method. Eggs were hatched in the absence of food to produce an arrested L1 population. Synchronously developing larvae were produced by feeding the starved L1 animals. Following 24 hours of development at 20° C, the L2/L3 molt animals were immobilized with 1 mM levamisole and examined using Nomarski optics for presence of daughter cells of recently divided VPCs. Although the timing of data collection undervalues the actual number of extra VPC divisions since extra divisions have been observed after the L2-to-L3 transition, the molt is a late event within the normal VPC quiescent period that provides a standardized developmental stage for direct comparisons. Cell-fate defects that disrupt cell fusion were analyzed using the AJM-1::GFP marker (Mohler et al., 1998) to visualize membrane boundaries which remain intact on VPCs. Animals displaying greater than six VPCs by the AJM-1 assay but not observed to undergo extra cell divisions by the Normarski assay were judged to be defective in cell-fate determination.

Molecular characterization of elm mutations

Newly isolated Elm strains were outcrossed at least two generations with N2 prior to characterization. The elm mutations were genetically mapped to a chromosome using the MT464 and MT465 triple-mutant strains. Because of the chromosomal locations and associated Muv phenotype of lin-1(he119), lin-1(he117) and lin-31(he136), these mutations were tested for complementation with their respective null alleles, lin-1(e1777) and lin-31(n301). mdt-13(he135) was localized to LGII between dpy-10 and unc-4 using three-factor mapping followed by CB4856-based SNP mapping (Wicks et al., 2001). The mdt-13(he135) mutant phenotype was rescued by introduction of a mix of overlapping cosmids T01B7, K08F8 and F07H5 or an approximately 13 kb PCR-generated genomic fragment containing the predicted gene K08F8.6. Sequence analysis identified the mutation within K08F8.6 of mdt-13(he135) animals. ref(he137) was localized to LGII and was examined for genetic complementation with ref-1(ok288). None of the ref(he137)/ref-1(ok288) trans-heterozygous animals (n=5 broods) displayed the Ref phenotype.

mdt-13 genetic analysis

For analyses of animals homozygous for the mdt-13(he135), mdt-13(mn19) or mnDf66 mutations, strains harboring the mutant chromosomes balanced by mIn1[dpy-10(e128) mIs14] were allowed to self-fertilize and non-GFP expressing animals were analyzed. These strains were intercrossed to examine hemizygotes (mdt-13(he135)/mnDf66 and mdt-13(mn19)/mnDf66) and trans-heterozygotes (mdt-13(he135)/mdt-13(mn19)). Double-stranded RNA corresponding to exon 12 of mdt-13 (between GAACTTGAA and ACACTTGGC) was injected into N2 hermaphrodite gonads to initiate RNAi. The mdt-13 deficient animals were categorized as embryonic lethal (Emb) if the eggs did not hatch, larval lethal (Let) if development arrested during larval stages or sterile (Ste) if adulthood was achieved. Between 62 and 108 individuals were examined for each genotype.

Results

A genetic screen for defective cell-cycle quiescence in C. elegans

We used pseudovulvae as indicators of VPC production in a genetic screen for mutant animals with more than six VPCs. Wild-type C. elegans produce six VPCs during the L1 stage that remain quiescent until the L3 stage. Gain-of-function mutations (gf) of the Notch family receptor encoded by lin-12 cause VPCs to develop into pseudovulvae, highly visible protrusions on the generally featureless contour of the adult worm body (compare Fig. 1B and 1C). Although the lin-12(gf)-induced pseudovulval structures are ectopic clusters of cells, each pseudovulva results from an abnormal cell-fate decision of a single VPC and not a defect in cell-cycle regulation ((Greenwald et al., 1983) and Table 2). Therefore, developmental defects that allow the production of greater than six VPCs, for example through defects in cell-cycle quiescence that allow extra cell divisions during the L1-to-L3 period, result in an easily detected increase in the number of adult pseudovulvae (Hong et al., 1998; Saito et al., 2004). We refer to the production of greater than six pseudovulvae by a lin-12(gf) adult as the Elm (enhancer of lin-12(gf) multivulva) phenotype.

Table 2.

A subset of genes mediating the VPC cell-fate decision were also required for normal VPC quiescence

genotype1 no. extra VPCs2 n3
N2 0 many
lin-12(n950) 0 71
lip-1(RNAi) 0 25
sli-1(RNAi) 0 26
let-60(n2022) 0 19
let-60(n1046gf) 0 20
let-60(ga89), 15°C 0 23
let-60(ga89), 25°C 0 25
gap-2(tm748) 0 38
sos-1(cs41), 15°C 0 24
sos-1(cs41), 25°C 0 30
mpk-1(ga117) 0 34
lin-1(he117) 0.03 ± 0.2 35
lin-1(he119) 0.08 ± 0.3 59
lin-1(e1777) 0.06 ± 0.3 31
lin-1(n304) 0.03 ± 0.2 63
lin-31(he136) 0.4 ± 0.9 64
lin-31(n301) 0.3 ± 0.5 49
lin-31(n1053) 0.3 ± 0.6 64
lin-31(n301); lin-1(he119) 0.8 ± 1.2 25
lin-31(n301); lin-1(he117) 0.8 ± 0.9 89
lin-31(he136); lin-35(RNAi) 1.4 ± 1.0 14
lin-1(he119); lin-35(RNAi) 0 35
lin-35(RNAi) 0 30
lin-25(e1446) 0.8 ± 0.6 44
mdt-23/sur-2(ku9) 0.6 ± 0.3 35
sur-5(RNAi) 0 25
lin-8(n2403); lin-36(n766) 0 19
lin-15(n765) 0 27
1

all strains were grown at 20° C, unless indicated.

2

presented as average number of VPCs displaying extra divisions/animal examined ± SD.

3

number of L2 animals examined.

We performed five variations of the Elm screen, each using a lin-12(gf) mutation as the basis of visualizing VPCs (Table 1). Version 1 utilized a strong gain-of-function allele, lin-12(n950). Although the screen successfully isolated elm mutations, including cdc-14(he118) (Saito et al., 2004), the lin-12(n950) produced abnormally small broods that severely reduced the observable sample size of the mutant strains during screening (Fig. 1D). Additionally, although they were generally self-fertile, lin-12(n950) mutant hermaphrodites were cross-sterile because of an inability to mate. To perform genetic analyses, cross-fertility could be inefficiently restored to the lin-12(n950) animals using RNAi-based methods to decrease the lin-12(gf) activity (Saito et al., 2004). Versions 2 through 4 (Table 1) bypassed the mating and fertility defects by using the cold-sensitive gain-of-function allele, lin-12(n137n460) (Greenwald et al., 1983), however, the weaker Muv phenotype was not optimal for Elm phenotype screening. The most effective solution to restore mating and fertility to the lin-12(n950)-containing strain was the addition of the lag-2(sa37) mutation (Tax et al., 1994). The lin-12(n950); lag-2(sa37) double mutant animals used in version 5 of the Elm screen produced a larger brood and restored cross fertility (Fig. 1D). Importantly, the lag-2(sa37) mutation did not significantly decrease production of the pseudovulvae as the lin-12(n950); lag-2(sa37) double mutant animals displayed similar pseudovulvae number compared to the lin-12(n950) single mutant strain. Because of the combination of these characteristics, the lin-12(n950); lag-2(sa37) double mutant animals became our primary strain for screening and characterization of new mutations that disrupt VPC developmental quiescence.

We isolated seven Elm mutant strains that represent six loci. Of these, five loci exhibited an extra VPC division defect, while one showed a cell-fate defect (see below and Fig. 1E). We determined the molecular identity of four loci that contribute to VPC cell-cycle quiescence. In addition to the previously described role of the phosphatase encoded by cdc-14 (Saito et al., 2004), we report here the identification of three transcriptional regulators identified in the screen.

One of the elm mutations disrupts Pn.p cell fate

Of the seven isolated Elm strains, only animals harboring the he137 mutation showed extra pseudovulvae that resulted from a cell-fate transformation (Fig. 2A). Transformation from a presumptive hypodermal cell into a VPC-like identity was previously observed upon loss of ref-1 or ref-2 (regulator of fusion), two genes that promote the hypodermal fate within a subset of Pn.p cells (Alper and Kenyon, 2001; Alper and Kenyon, 2002). In animals deficient for either ref-1 or ref-2, posterior Pn.p cells (P9.p - P11.p) forego the syncytial hypodermal fate and instead adopt VPC-like characteristics, including maintenance of an autonomous cell boundary that can be observed using the AJM-1::GFP marker (Francis and Waterston, 1991; Mohler et al., 1998). Since the he137 mutation genetically mapped to Chromosome II which contains the ref-1 locus, he137 was tested for genetic complementation of ref-1(ok288) (Materials and Methods). As measured by the Ref phenotype, functional complementation between he137 and ref-1(ok288) strongly suggested that the he137 mutation does not disrupt ref-1. Since we are interested in Elm mutations that disrupt cell-cycle regulation, we focused our analyses on the remaining elm genes.

Fig. 2.

Fig. 2

The Elm phenotype reveals extra VPCs that result from defects in either cell-fate or cell-cycle quiescence. (A) The Elm phenotype of the ref(he137) mutant adult. Notice the posterior appearance of the extra pseudovulvae due to abnormal VPC-fate adoption by presumptive hypodermal Pn.p cells. Mutations of two targets of Ras signaling, lin-1 (B) and lin-31 (C), result in the Elm phenotype. An extraordinarily robust lin-31; lin-12 mutant adult is shown. Asterisks indicate pseudovulvae. Animals are oriented as anterior, left and dorsal, up.

LIN-1, an Ets-family transcription factor, contributes to VPC quiescence

Two lin-1 alleles, he117 and he119, were identified that permitted an extremely low frequency of extra VPC divisions (Fig. 1E and Table 2). The defect is observed as one extra VPC division approximately every thirtieth animal. The lin-1-encoded Ets-family transcription factor has been described to inhibit the 1° vulval cell fate (Beitel et al., 1995). Accordingly, lin-1(he117) and lin-1(he119) mutant adults displayed the Muv phenotype (Fig. 2B). We determined that strains harboring the null alleles lin-1(e1777) and lin-1(n304) also exhibited the weak defect in VPC cell-cycle quiescence (Table 2), indicating that the extra cell division defects are inherent to lin-1 loss of function. The lin-1(he117) mutation introduced a premature stop at codon 99 (Glutamic acid) within the Ets domain encoding sequence while the lin-1(he119) mutation has not yet been identified (Miley et al., 2004). Therefore, the isolation of lin-1 mutations in the Elm screen for extra VPC divisions revealed a previously unrecognized role for lin-1 in the developmental quiescence of VPCs.

LIN-31, Forkhead (foxB) transcription factor, is required for proper VPC quiescence

LIN-31, a member of the winged-helix/Forkhead box (Fox) family of transcriptional regulators (Miller et al., 1993), has been demonstrated to associate with LIN-1 during cell-fate determination by the VPCs (Tan et al., 1998). Consistent with the physical interaction with LIN-1, animals deficient for lin-31 activity also display extra VPC divisions during the normal quiescent period as well as a Muv phenotype ((Miller et al., 1993) (Miller et al., 2000), Fig. 2C and Table 2). Similar to other strong loss-of-function alleles, lin-31(he136) disrupts the predicted DNA-binding domain by changing the Serine at amino acid position 60 to Phenylalanine. Based on the extra VPC phenotype, lin-31(he136) was indistinguishable from the null allele, lin-31(n1053) (Table 2). Since the progeny cells produced by the extra divisions retained the VPC identity as demonstrated by the ability to produce pseudovulvae in the lin-12(gf) background, the ectopic cell divisions are the result of a defect in cell-cycle control and not heterochronic or other cell-fate abnormalities. Therefore, given the interaction between lin-1 and lin-31 during cell-fate determination, isolation of mutations within both loci in the Elm screen suggests a similar cooperation during VPC cell-cycle regulation.

lin-1 and lin-31 promote VPC quiescence by regulating cki-1 expression

Since lin-1 and lin-31 encode members of conserved transcription factor families, we examined genes that control cell-cycle entry and exit as potential targets of regulation. We observed that the normal pattern of expression of cki-1, which encodes a CIP/KIP-related cyclin-dependent kinase inhibitor (Hong et al., 1998), requires lin-1 and lin-31 activities (Fig. 3). We compared the expression of a GFP reporter driven by an 8 kb fragment of the cki-1 promoter in wild-type, lin-1(he119) and lin-31(n1053) animals. The location and timing of GFP expression from this reporter coincided with cki-1 activity during development (Hong et al., 1998). Within the ventral cord of all strains examined, the terminally differentiated neurons adjacent to the VPCs expressed the cki-1::GFP reporter. In contrast, unlike the robust expression observed in the wild-type animals during L2, the GFP expression by the VPCs of either lin-1 or lin-31 mutant animals was consistently reduced or not detected (Fig. 3). The decreased GFP expression indicated that lin-1 and lin-31 activities were required for efficient activation of the cki-1 promoter in the newly formed VPCs at a time consistent with its role in cell-cycle quiescence. We did not observe appreciable changes to reporter expression in other tissues. These findings suggested that lin-1 and lin-31 control cki-1 expression in a tissue-restricted manner and that the extra cell divisions observed in the lin-1 and lin-31 mutants are the result of decreased transcription of cki-1 Cip/Kip.

Fig. 3.

Fig. 3

Activation of the cki-1 promoter in arresting VPCs requires lin-1 and lin-31 activities. Nomarski (A, C and E) and epifluorescence (B, D and F) images of L2 animals expressing a cki-1::gfp reporter within the ventral cord (Hong et al., 1998). Compared to age-matched wild-type background (A and B), lin-1(he119) (C and D) and lin-31(he136) (E and F) mutant animals display weak or no detectable GFP expression above background. Animals are oriented as anterior, left and dorsal, up. The arrows indicate the VPCs, P6.p and P7.p. GFP expression is also observed within ventral cord neurons including the Pn.a descendants. (E) Quantitation of GFP signal within the VPC nuclei of the indicated genetic background (n ≥ 10).

In several developmentally regulated cell cycles, including those of the VPCs, cki-1 acts in parallel to a pathway that includes the sole C. elegans Retinoblastoma family member, lin-35 (Boxem and van den Heuvel, 2001). If lin-1 and lin-31 act within the cki-1-mediated pathway by promoting cki-1 expression, then simultaneous loss of lin-35 activity in the lin-31 or lin-1 mutant animals should enhance the Elm phenotype. While lin-35(RNAi) did not enhance the rare extra divisions found in lin-1(he119), the number of extra VPC divisions in lin-31(he136) mutant animals was significantly increased upon lin-35(RNAi) treatment (Table 2), consistent with a role for lin-31 in promoting cki-1 expression.

We examined the Elm phenotype of cki-1(gk132) heterozygotes for enhancement upon further loss of lin-1 to obtain genetic evidence of lin-1 as a regulator of cki-1 expression. Similar to the haploinsufficiency reported for p27 in mouse and humans (Philipp-Staheli et al., 2001), cki-1 heterozygous mutant animals display a cell-cycle quiescence defect ((Saito et al., 2004) and Table 3). As expected if lin-1 promotes cki-1 expression, the cki-1(gk132)/+; lin-1(he119) animals displayed increased extra VPC divisions compared to cki-1(gk132)/+ animals (Table 3). Similar analysis of lin-31 was not performed because of the genetic linkage between lin-31 and cki-1. The enhanced Elm phenotype observed in lin-35(RNAi); lin-31(he136) and cki-1(gk132)/+; lin-1(he119) animals support a model in which the cell-cycle quiescence of the VPCs is controlled by non-overlapping activities of lin-35 and a pathway mediated by lin-1, lin-31 and cki-1.

Table 3.

Genetic interactions support lin-1 and lin-31 regulation of cki-1 expression

genotype no. extra VPCs1 n2
cki-1(gk132)/+ 0.3 ± 0.5 22
cki-1(gk132)/+; lin-1(he119) 0.6 ± 0.7 22
cdc-14(he118) 3.0 ± 1.2 23
cdc-14(he118); lin-1(e1777) 2.9 ± 0.9 30
cdc-14(he118); lin-1(n1761gf) 1.9 ± 1.23 17
lin-31(n301) cdc-14(he118) 4.1 ± 1.0 29
1

presented as average number of VPCs displaying extra divisions/animal examined ± SD.

2

number of L2 animals examined.

3

P ≤ 0.01, comparison between cdc-14(he118) and cdc-14(he118); lin-1(n1761gf)

Lastly, evidence of cki-1 as a downstream target of lin-1 and lin-31 regulation during VPC quiescence was obtained by analyzing genetic interactions between lin-1, lin-31 and cdc-14. cdc-14 encodes a phosphatase that positively regulates cki-1 activity, most likely through control of CKI-1 stability or localization (Saito et al., 2004). The extra cell divisions in the cdc-14 mutant animals were suppressed by increased cki-1 expression (Saito et al., 2004). If lin-1, lin-31 and cdc-14 encourage cell-cycle quiescence by promoting cki-1 expression and activity, respectively, lin-1 gain of function might reduce the defects caused by cdc-14 loss of function. Indeed, the lin-1(n1761gf) mutation partially, but significantly (p≤0.01), suppressed the extra cell division defect of cdc-14(he118) null mutants (Table 3). Conversely, loss of lin-1 or lin-31 activities together with cdc-14 mutation should result in greater penetrance of the extra division defect. We observed an enhanced extra cell-cycle phenotype in the lin-31 cdc-14 double mutant animals (Table 3). Together with the previous results the genetic interactions with cdc-14(he118) indicate that lin-1 and lin-31 promote cki-1 activity during VPC quiescence.

lin-1 and lin-31 may affect VPC quiescence independent of the let-60 Ras pathway

lin-1 and lin-31 encode well-characterized targets of a RTK/Ras/MAPK signaling cascade that directs cell-fate specification of the quiescent VPCs beginning late in the L2 stage (reviewed in (Sternberg, 2005)). If the contribution of lin-1 and lin-31 in VPC quiescence reflect their roles in the RTK/Ras/MAPK cascade, then mutations of other genes acting within the pathway may also result in the Elm phenotype. We examined genes that control the VPC cell-fate decision for earlier requirements during the cell-cycle quiescent period. Mutations that activate or inactivate RTK/Ras/MAPK signaling upstream of LIN-1 and LIN-31 did not cause extra VPC divisions between the mid-L1 and mid-L3 stage (Table 2). Thus, the roles of lin-1 and lin-31 in establishing or maintaining VPC quiescence are likely independent of their previously described roles as targets of the RTK/Ras/MAPK cascade. However, lin-25 and mdt-23/sur-2, two genes with roles in VPC cell fate determination were found to also affect VPC quiescence (Table 2 and (Ferguson et al., 1987)). The products of these genes likely act in conjunction with the multi-subunit Mediator complex, a coregulator of RNA polymerase II transcription (see below).

TRAP240 is required for proper control of VPC quiescence

A mutation within the gene encoding the C. elegans TRAP240 homolog, mdt-13, was isolated in the Elm screen. The TRAP240 subunit is associated with the Cdk8 module (or Srb8-11 in yeast) of the Mediator complex that is implicated in negative regulation of transcription by RNA polymerase II (Carlson, 1997; Hengartner et al., 1998; Sun et al., 1998; Taatjes et al., 2002; van de Peppel et al., 2005). As would be expected for a generally used transcriptional regulator, homozygous mdt-13(he135) mutant animals displayed a complex phenotype indicating pleotropic functions. mdt-13(he135) animals derived from heterozygous mothers were small and sterile, superficially appearing developmentally arrested as late larvae. However, adult structures such as alae and vulvae were produced. When examined at the L2 molt, these homozygous mdt-13(he135) animals displayed a potent extra VPC phenotype (2.3 ± 0.9 average extra VPC divisions per worm, n=10 and Fig. 4A). In mdt-13(he135); lin-12(n950) double mutant animals, the extra VPCs created during larval development contributed to a robust adult Elm phenotype (Fig. 4B). DNA sequence analysis showed that mdt-13(he135) introduced a premature truncation at codon position 259 (Tryptophan-to-Opal mutation). Moreover, we examined a previously identified allele, mdt-13(mn19) (Yoda et al., 2005), and observed an equally penetrant extra cell division phenotype (data not shown). Together, these mutations revealed a crucial requirement for mdt-13 function in the establishment and/or maintenance of VPC developmental quiescence.

Fig. 4.

Fig. 4

The mdt-13 requirement in VPC cell-cycle quiescence is revealed by mutations that reduce activity. (A) Extra VPC divisions are observed during the normally quiescent L2 stage in the mdt-13(he135) mutant animals. Arrows indicate VPCs. In this example, the VPC, P5.p, has undergone an extra division (forked arrow). (B) The extra VPCs can be visualized as pseudovulvae (asterisks) on the mdt-13(he135); lin-12(n950) mutant adults. (C) Genetic analyses of the mdt-13(he135) and mdt-13(mn19) alleles indicate that the mutation partially disrupts mdt-13 activity. Animals of the indicated genotypes were characterized by phenotype as normal (wt), embryonic lethal (Emb), larval lethal (Let) or sterile adult (Ste).

Genetic analyses indicated that the mdt-13(he135) and mdt-13(mn19) mutations result in partial loss of function. The majority of mdt-13(he135) and mdt-13(mn19) mutant animals developed into small, sterile adults (87% and 89% Ste, respectively, Fig. 4C). However, more severe developmental defects resulted from trans-heterozygous combinations of either mutation with mnDf66, a chromosomal deletion that eliminates the mdt-13 locus (Fig. 4C). The increase of embryonic and larval lethality of the hemizygous mutant animals indicated that the mutations result in a partial loss of function. Since the mdt-13 mutant strains were maintained as heterozygotes with a wild-type allele, the homozygous progeny may use maternally contributed mdt-13 activity to fulfill an embryonic requirement. Accordingly, inhibition of maternal as well as zygotic mdt-13 function by RNAi resulted in completely penetrant embryonic lethality (Fig. 4C). These data indicate a general requirement for mdt-13 during development. This is further supported by ubiquitous expression of transgenes containing the mdt-13 promoter driving expression of the green fluorescent protein (GFP) ((Wang et al., 2004) and data not shown). Importantly, despite the essential function of mdt-13 for viability, mutations reducing mdt-13 function revealed a critical role in cell-cycle arrest of the VPCs.

A subset of Mediator components is required for VPC cell-cycle quiescence

The observations that VPC cell-cycle quiescence required the Mediator-associated genes mdt-13, mdt-23/sur-2 and lin-25 prompted us to systematically examine predicted C. elegans components of the Mediator complex. The Mediator subunits are functionally and structurally conserved throughout eukaryotes and most components have readily identifiable C. elegans counterparts ((Bourbon et al., 2004) and Table 4). To determine if a Mediator subunit was necessary for VPC quiescence, we examined animals treated with RNAi to inhibit the expression of the subunit or, when available, we examined animals with disabling genetic mutations. Many Mediator subunits appear essential for normal development and viability as loss of function by either mutation or RNAi yielded a spectrum of defects that included embryonic and larval lethality (Let, Table 4). For these Mediator genes, VPC quiescence was examined in the “escapers”, the animals that survive and develop more extensively than their broodmates exposed to the lethal RNAi conditions. By examining mutant animals at the L2/L3 molt, we found that several Mediator components are required for establishing or maintaining VPC cell-cycle quiescence. Notably, in addition to the previously described mdt-13, sur-2/mdt-23 and lin-25 defects, extra VPC divisions were observed following RNAi-mediated inhibition of cdk-8 (0.3 ± 0.5 average extra VPC divisions per worm, n=12), mdt-1/sop-3 (0.1 ± 0.3 extra, n=30) and mdt-12/sop-1 (0.1 ± 0.3 extra, n=32) activities, which encode homologs of Cdk8, TRAP220 and TRAP230, respectively. Interestingly, the Mediator components we identified based on their roles in VPC quiescence largely correspond to the Cdk8 module (Borggrefe et al., 2002; Carlson, 1997). This module is associated with a subset of Mediator complexes and has been implicated in transcriptional repression (see discussion).

Table 4.

A subset of Mediator genes control VPC quiescence

C. elegans gene homolog Let Elm
mdt-1/sop-3 TRAP220/Med1 + +
mdt-7/let-49 Med7 + -
mdt-8 Med8 + -
mdt-10 Nut2/Med10 + -
mdt-11 Med11 - -
mdt-12/sop-1/dpy-22 Trap230/Med12 + +
mdt-13/let-191 Trap240/Med13 + +
mdt-14 Rgr1/Med14 + -
mdt-15 Arc105/Med15 - -
mdt-18 Srb5/Med18 + -
mdt-19 Rox3/Med19 + -
mdt-22 Srb6/Med22 + -
mdt-23/sur-22 Sur2/Med23 - +
mdt-27 Trap37/Med27 - -
mdt-28 Med28 - -
mdt-29 Med29 - -
mdt-31 Soh1/Med31 + -
cdk-81 Srb10/Cdk8 - +
cic-1 Srb11/Cyclin C - -

Phenotypes were produced by RNAi treatment, unless otherwise noted:

1

phenotype examined in mutant animal and by RNAi treatment.

2

phenotype examined in mutant animal only.

DISCUSSION

The genes identified in our Elm mutant screen are required for the normal period of cell-cycle quiescence exhibited by the VPCs starting in the L1 stage of development. Two of the genes, lin-1 and lin-31, encode transcription factors that control the cell-fate decision of the quiescent VPCs. However, the quiescence and cell-fate decisions are independent processes since several other genes controlling cell-fate selection by the VPCs did not display roles in regulating quiescence. Indeed, the Elm phenotype targeted by the screen depends on the ability of the cells to respond to the lin-12(gf) signal and therefore mutations that significantly alter the VPC identity could not be isolated from this screen. The screen also revealed a specific role in cell-cycle regulation for several components of the Mediator complex. Despite a general requirement for these transcriptional regulatory complexes, a specific function to regulate cell-cycle quiescence was revealed in our studies. To date, six of the seven strains identified by the Elm screen displayed defects in VPC cell-cycle regulation, indicating that the Elm screen provides a sensitive method for identification of genes that contribute to developmental control of cell division in C. elegans.

Contribution of cki-1 transcriptional regulation by LIN-1 and LIN-31 to VPC quiescence

Upon identification of lin-1 and lin-31 in the Elm screen, we focused on cki-1 as a candidate target gene and cell-cycle quiescence effector for several reasons. First, the mutant phenotypes display common characteristics, including enhancement by loss of lin-35 activity ((Boxem and van den Heuvel, 2001) and Table 2). Second, the Fox family member, AFX, controls expression of p27 in Humans and mice (Medema et al., 2000). Third, over twenty consensus binding sites for Ets and Forkhead DNA-binding domains are contained within the cki-1 promoter fragment that confers VPC expression concurrent with the initiation of cell-cycle quiescence ((Hong et al., 1998) and not shown). It is noteworthy that we observed a specific requirement within the VPCs for both lin-1 and lin-31 activities in expression of a cki-1 promoter-driven GFP reporter. Intriguingly, the defect in cki-1 promoter activation observed in the lin-1 and lin-31 deficient animals correlates with the penetrance of the cell-cycle quiescence defect of the mutant animals. Together, these findings support that lin-1 and lin-31 promote the expression of cki-1 during the establishment or maintenance of cell-cycle quiescence.

Studies of cell-cycle regulation during Drosophila eye development proposed a “mop up” function for CKIs such as p27 during the establishment of cell-cycle quiescence (de Nooij et al., 1996). In their model of regulated cell-cycle quiescence, the role of the p27 family member encoded by the Dacapo gene is to bind and inactivate residual cyclin/CDK complexes that escaped inactivation during the previous cycle. This mop up function allows greater control of the activities of G1 CDKs to achieve a strict enforcement of cell-cycle quiescence. Observations of cki-1-deficient development in C. elegans support the mop up model. In cki-1 deficient animals, cells such as the VPCs do not show uncontrolled proliferation. On the contrary, on average each VPC undergoes only a single extra division and despite the resulting extra VPCs, development continued unperturbed (Boxem and van den Heuvel, 2001; Hong et al., 1998). For example, the progeny cells produced from a VPC that circumvents quiescence and undergoes an extra division during L2 will subsequently resume divisions in L3 at the normal time (Hong et al., 1998; Saito et al., 2004). Since these later divisions are performed by cells that are essentially “younger” than those in wild type, a mechanism utilizing a cell-intrinsic timer to regulate divisions is highly unlikely. The single extra cell cycle in the absence of cki-1 activity is consistent with an unchecked activity of residual CDK complexes: uncontrolled proliferation was not observed since a constitutive proliferation signal was not provided. In contrast, the VPCs of animals deficient for both cki-1 and lin-35 activities can undergo two or more rounds of cell division during the normal quiescent period ((Boxem and van den Heuvel, 2001) and not shown). These observations are consistent with the mop up model in which residual cyclin activity in the cki-1 mutants lead to but are degraded during the extra cell cycle, however, the increased expression of cyclin E allowed by loss of lin-35 Rb function may promote further cell divisions.

VPC cell-cycle quiescence selectively requires components of the Mediator complex

Although Mediator is thought to generally regulate activated RNA polymerase II transcription (Kornberg, 2005), the effect on a specific gene depends on the cellular and developmental context (Yoda et al., 2005) and the composition of the complex (Taatjes et al., 2002). Biochemical studies have demonstrated that the large, multi-subunit Mediator complex exists in several forms that bridge site-specific DNA-binding proteins and the RNA polymerase II holoenzyme to regulate transcription. The homologs of CDK-8, MDT-12, MDT-13 and CIC-1 constitute a biochemically distinct Mediator subcomplex, referred to as the Cdk8 module, that interacts with the core components through an interaction with MDT-1 (Borggrefe et al., 2002; Carlson, 1997). Therefore, it is significant that we observed specific requirements for cdk-8, mdt-12, mdt-13 and mdt-1 during regulation of VPC cell cycles. Defects in cell-cycle entry were not observed following RNAi of cic-1; however, we were unable to determine the efficacy of cic-1(RNAi) treatment. Moreover, co-immunoprecipitation experiments demonstrated that SUR-2 associated with MDT-13-containing Mediator complex in vivo (Yoda et al., 2005). Our demonstration that these Mediator subunits are necessary for the control of cell-cycle quiescence is consistent with the biochemical evidence that they constitute a functional unit.

In our studies, loss of the Mediator component encoded by mdt-13 caused a significant number of extra cell divisions. Unlike lin-1 and lin-31, mdt-13 does not appear to regulate the cell cycle through control of cki-1 expression, since the mdt-13(he135) mutation did not appreciably reduce expression of the cki-1::GFP reporter in the VPCs (data not shown). In fact, Mediator complexes in yeast and mammalian systems that contain the Cdk8 module do not activate transcription of target genes, on the contrary, they likely inhibit activation (Carlson, 1997; Hengartner et al., 1998; Holstege et al., 1998; Sun et al., 1998; Taatjes et al., 2002; van de Peppel et al., 2005). Based on these observations we predict that the extra cell division phenotype displayed by mdt-13(he135) mutant animals results from ectopic expression of genes that promote cell-cycle progression. However, we did not observe alteration of C. elegans cyd-1 cyclin D or cye-1 cyclin E promoter activation in the VPCs of mdt-13 mutant animals (data not shown). Wang et al concluded from decreased reporter gene expression following RNAi knockdown that mdt-13 can activate transcription of certain target genes (Wang et al., 2004). Thus, it remains possible that the critical targets of the Cdk8 module-associated Mediator complex in VPC quiescence include cell-cycle inhibitors. In order to delineate the total contribution of Mediator to VPC cell-cycle quiescence, a comprehensive description of the regulatory targets and their dependence on Mediator components will be necessary.

Concluding remarks

Our results demonstrate that the Elm screen presents a valid approach to identify C. elegans genes necessary for VPC quiescence during development. Since the normal function of the genes identified is to arrest cell division, their human homologs represent candidate tumor suppressors. We identified multiple mutations that disrupt normal cell-cycle quiescence of the VPCs. The identities of three genes isolated in the Elm screen, lin-1, lin-31 and mdt-13, and their subsequent characterizations illustrate the important roles played by transcriptional regulation in the developmental control of cell division. Therefore, further identification of elm genes to complete the description of the developmental network controlling cell-cycle quiescence will provide further insights towards our understanding of how the decision to divide during normal development is made.

Acknowledgments

We thank Victor Ambros, Patricia Ernst, Larry Myers and anonymous reviewers for careful reading and commenting on the manuscript. Some nematode strains used in this work were provided by the National BioResource Project (NBRP) and the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). This work was funded by the National Institutes of Health (SvdH), American Cancer Society (PF-98-114-01-DDC and IRG-82-003-21), the MGH fund for Medical Discovery and the Howard Hughes Medical Institute (76200-560801 to Dartmouth Medical School under the Biomedical Research Support Program for Medical Schools) (RMS).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Alper S, Kenyon C. REF-1, a protein with two bHLH domains, alters the pattern of cell fusion in C. elegans by regulating Hox protein activity. Development. 2001;128:1793–804. doi: 10.1242/dev.128.10.1793. [DOI] [PubMed] [Google Scholar]
  2. Alper S, Kenyon C. The zinc finger protein REF-2 functions with the Hox genes to inhibit cell fusion in the ventral epidermis of C. elegans. Development. 2002;129:3335–48. doi: 10.1242/dev.129.14.3335. [DOI] [PubMed] [Google Scholar]
  3. Ambros V, Horvitz HR. Heterochronic mutants of the nematode Caenorhabditis elegans. Science. 1984;226:409–16. doi: 10.1126/science.6494891. [DOI] [PubMed] [Google Scholar]
  4. Aroian RV, Koga M, Mendel JE, Ohshima Y, Sternberg PW. The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily. Nature. 1990;348:693–9. doi: 10.1038/348693a0. [DOI] [PubMed] [Google Scholar]
  5. Beitel GJ, Tuck S, Greenwald I, Horvitz HR. The Caenorhabditis elegans gene lin-1 encodes an ETS-domain protein and defines a branch of the vulval induction pathway. Genes Dev. 1995;9:3149–62. doi: 10.1101/gad.9.24.3149. [DOI] [PubMed] [Google Scholar]
  6. Binne UK, Classon MK, Dick FA, Wei W, Rape M, Kaelin WG, Jr., Naar AM, Dyson NJ. Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nat Cell Biol. 2007;9:225–32. doi: 10.1038/ncb1532. [DOI] [PubMed] [Google Scholar]
  7. Borggrefe T, Davis R, Erdjument-Bromage H, Tempst P, Kornberg RD. A complex of the Srb8, -9, -10, and -11 transcriptional regulatory proteins from yeast. J Biol Chem. 2002;277:44202–7. doi: 10.1074/jbc.M207195200. [DOI] [PubMed] [Google Scholar]
  8. Bourbon HM, Aguilera A, Ansari AZ, Asturias FJ, Berk AJ, Bjorklund S, Blackwell TK, Borggrefe T, Carey M, Carlson M, Conaway JW, Conaway RC, Emmons SW, Fondell JD, Freedman LP, Fukasawa T, Gustafsson CM, Han M, He X, Herman PK, Hinnebusch AG, Holmberg S, Holstege FC, Jaehning JA, Kim YJ, Kuras L, Leutz A, Lis JT, Meisterernest M, Naar AM, Nasmyth K, Parvin JD, Ptashne M, Reinberg D, Ronne H, Sadowski I, Sakurai H, Sipiczki M, Sternberg PW, Stillman DJ, Strich R, Struhl K, Svejstrup JQ, Tuck S, Winston F, Roeder RG, Kornberg RD. A unified nomenclature for protein subunits of mediator complexes linking transcriptional regulators to RNA polymerase II. Mol Cell. 2004;14:553–7. doi: 10.1016/j.molcel.2004.05.011. [DOI] [PubMed] [Google Scholar]
  9. Boxem M, van den Heuvel S. lin-35 Rb and cki-1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans. Development. 2001;128:4349–59. doi: 10.1242/dev.128.21.4349. [DOI] [PubMed] [Google Scholar]
  10. Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77:71–94. doi: 10.1093/genetics/77.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Carlson M. Genetics of transcriptional regulation in yeast: connections to the RNA polymerase II CTD. Annu Rev Cell Dev Biol. 1997;13:1–23. doi: 10.1146/annurev.cellbio.13.1.1. [DOI] [PubMed] [Google Scholar]
  12. Chi W, Reinke V. Promotion of oogenesis and embryogenesis in the C. elegans gonad by EFL-1/DPL-1 (E2F) does not require LIN-35 (pRB) Development. 2006;133:3147–57. doi: 10.1242/dev.02490. [DOI] [PubMed] [Google Scholar]
  13. Cui M, Chen J, Myers TR, Hwang BJ, Sternberg PW, Greenwald I, Han M. SynMuv genes redundantly inhibit lin-3/EGF expression to prevent inappropriate vulval induction in C. elegans. Dev Cell. 2006;10:667–72. doi: 10.1016/j.devcel.2006.04.001. [DOI] [PubMed] [Google Scholar]
  14. de Nooij JC, Letendre MA, Hariharan IK. A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell. 1996;87:1237–47. doi: 10.1016/s0092-8674(00)81819-x. [DOI] [PubMed] [Google Scholar]
  15. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998;12:2245–62. doi: 10.1101/gad.12.15.2245. [DOI] [PubMed] [Google Scholar]
  16. Ekholm SV, Reed SI. Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol. 2000;12:676–84. doi: 10.1016/s0955-0674(00)00151-4. [DOI] [PubMed] [Google Scholar]
  17. Euling S, Ambros V. Heterochronic genes control cell cycle progress and developmental competence of C. elegans vulva precursor cells. Cell. 1996;84:667–76. doi: 10.1016/s0092-8674(00)81045-4. [DOI] [PubMed] [Google Scholar]
  18. Fay DS, Yochem J. The SynMuv genes of Caenorhabditis elegans in vulval development and beyond. Dev Biol. 2007;306:1–9. doi: 10.1016/j.ydbio.2007.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ferguson EL, Sternberg PW, Horvitz HR. A genetic pathway for the specification of the vulval cell lineages of Caenorhabditis elegans. Nature. 1987;326:259–67. doi: 10.1038/326259a0. [DOI] [PubMed] [Google Scholar]
  20. Francis R, Waterston RH. Muscle cell attachment in Caenorhabditis elegans. J Cell Biol. 1991;114:465–79. doi: 10.1083/jcb.114.3.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Greenwald IS, Sternberg PW, Horvitz HR. The lin-12 locus specifies cell fates in Caenorhabditis elegans. Cell. 1983;34:435–44. doi: 10.1016/0092-8674(83)90377-x. [DOI] [PubMed] [Google Scholar]
  22. Grishok A, Sharp PA. Negative regulation of nuclear divisions in Caenorhabditis elegans by retinoblastoma and RNA interference-related genes. Proc Natl Acad Sci U S A. 2005;102:17360–5. doi: 10.1073/pnas.0508989102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Han M, Golden A, Han Y, Sternberg PW. C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation. Nature. 1993;363:133–40. doi: 10.1038/363133a0. [DOI] [PubMed] [Google Scholar]
  24. Han M, Sternberg PW. let-60, a gene that specifies cell fates during C. elegans vulval induction, encodes a ras protein. Cell. 1990;63:921–31. doi: 10.1016/0092-8674(90)90495-z. [DOI] [PubMed] [Google Scholar]
  25. Hengartner CJ, Myer VE, Liao SM, Wilson CJ, Koh SS, Young RA. Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol Cell. 1998;2:43–53. doi: 10.1016/s1097-2765(00)80112-4. [DOI] [PubMed] [Google Scholar]
  26. Hill RJ, Sternberg PW. The gene lin-3 encodes an inductive signal for vulval development in C. elegans. Nature. 1992;358:470–6. doi: 10.1038/358470a0. [DOI] [PubMed] [Google Scholar]
  27. Holstege FC, Jennings EG, Wyrick JJ, Lee TI, Hengartner CJ, Green MR, Golub TR, Lander ES, Young RA. Dissecting the regulatory circuitry of a eukaryotic genome. Cell. 1998;95:717–28. doi: 10.1016/s0092-8674(00)81641-4. [DOI] [PubMed] [Google Scholar]
  28. Hong Y, Roy R, Ambros V. Developmental regulation of a cyclin-dependent kinase inhibitor controls postembryonic cell cycle progression in Caenorhabditis elegans. Development. 1998;125:3585–97. doi: 10.1242/dev.125.18.3585. [DOI] [PubMed] [Google Scholar]
  29. Howard RM, Sundaram MV. C. elegans EOR-1/PLZF and EOR-2 positively regulate Ras and Wnt signaling and function redundantly with LIN-25 and the SUR-2 Mediator component. Genes Dev. 2002;16:1815–27. doi: 10.1101/gad.998402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kato Y, Habas R, Katsuyama Y, Naar AM, He X. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling. Nature. 2002;418:641–6. doi: 10.1038/nature00969. [DOI] [PubMed] [Google Scholar]
  31. Kirienko NV, Fay DS. Transcriptome profiling of the C. elegans Rb ortholog reveals diverse developmental roles. Dev Biol. 2007;305:674–84. doi: 10.1016/j.ydbio.2007.02.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kornberg RD. Mediator and the mechanism of transcriptional activation. Trends Biochem Sci. 2005;30:235–9. doi: 10.1016/j.tibs.2005.03.011. [DOI] [PubMed] [Google Scholar]
  33. Lackner MR, Kim SK. Genetic analysis of the Caenorhabditis elegans MAP kinase gene mpk-1. Genetics. 1998;150:103–17. doi: 10.1093/genetics/150.1.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Medema RH, Kops GJ, Bos JL, Burgering BM. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature. 2000;404:782–7. doi: 10.1038/35008115. [DOI] [PubMed] [Google Scholar]
  35. Miley GR, Fantz D, Glossip D, Lu X, Saito RM, Palmer RE, Inoue T, Van Den Heuvel S, Sternberg PW, Kornfeld K. Identification of residues of the Caenorhabditis elegans LIN-1 ETS domain that are necessary for DNA binding and regulation of vulval cell fates. Genetics. 2004;167:1697–709. doi: 10.1534/genetics.104.029017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Miller LM, Gallegos ME, Morisseau BA, Kim SK. lin-31, a Caenorhabditis elegans HNF-3/fork head transcription factor homolog, specifies three alternative cell fates in vulval development. Genes Dev. 1993;7:933–47. doi: 10.1101/gad.7.6.933. [DOI] [PubMed] [Google Scholar]
  37. Miller LM, Hess HA, Doroquez DB, Andrews NM. Null mutations in the lin-31 gene indicate two functions during Caenorhabditis elegans vulval development. Genetics. 2000;156:1595–602. doi: 10.1093/genetics/156.4.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mohler WA, Simske JS, Williams-Masson EM, Hardin JD, White JG. Dynamics and ultrastructure of developmental cell fusions in the Caenorhabditis elegans hypodermis. Curr Biol. 1998;8:1087–90. doi: 10.1016/s0960-9822(98)70447-6. [DOI] [PubMed] [Google Scholar]
  39. Park M, Krause MW. Regulation of postembryonic G1 cell cycle progression in Caenorhabditis elegans by a cyclin D/CDK-like complex. Development. 1999;126:4849–60. doi: 10.1242/dev.126.21.4849. [DOI] [PubMed] [Google Scholar]
  40. Park MS, Rosai J, Nguyen HT, Capodieci P, Cordon-Cardo C, Koff A. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc Natl Acad Sci U S A. 1999;96:6382–7. doi: 10.1073/pnas.96.11.6382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Philipp-Staheli J, Payne SR, Kemp CJ. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res. 2001;264:148–68. doi: 10.1006/excr.2000.5143. [DOI] [PubMed] [Google Scholar]
  42. Saito RM, Perreault A, Peach B, Satterlee JS, van den Heuvel S. The CDC-14 phosphatase controls developmental cell-cycle arrest in C. elegans. Nat Cell Biol. 2004;6:777–83. doi: 10.1038/ncb1154. [DOI] [PubMed] [Google Scholar]
  43. Simske JS, Kim SK. Sequential signalling during Caenorhabditis elegans vulval induction. Nature. 1995;375:142–6. doi: 10.1038/375142a0. [DOI] [PubMed] [Google Scholar]
  44. Singh N, Han M. sur-2, a novel gene, functions late in the let-60 ras-mediated signaling pathway during Caenorhabditis elegans vulval induction. Genes Dev. 1995;9:2251–65. doi: 10.1101/gad.9.18.2251. [DOI] [PubMed] [Google Scholar]
  45. Sternberg PW. Vulval development. In: Community T. C. e. R., editor. WormBook. WormBook; 2005. pp. 1551–8507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sulston JE, Horvitz HR. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol. 1977;56:110–56. doi: 10.1016/0012-1606(77)90158-0. [DOI] [PubMed] [Google Scholar]
  47. Sun X, Zhang Y, Cho H, Rickert P, Lees E, Lane W, Reinberg D. NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol Cell. 1998;2:213–22. doi: 10.1016/s1097-2765(00)80131-8. [DOI] [PubMed] [Google Scholar]
  48. Taatjes DJ, Naar AM, Andel F, 3rd, Nogales E, Tjian R. Structure, function, and activator-induced conformations of the CRSP coactivator. Science. 2002;295:1058–62. doi: 10.1126/science.1065249. [DOI] [PubMed] [Google Scholar]
  49. Tan PB, Lackner MR, Kim SK. MAP kinase signaling specificity mediated by the LIN-1 Ets/LIN-31 WH transcription factor complex during C. elegans vulval induction. Cell. 1998;93:569–80. doi: 10.1016/s0092-8674(00)81186-1. [DOI] [PubMed] [Google Scholar]
  50. Tax FE, Yeargers JJ, Thomas JH. Sequence of C. elegans lag-2 reveals a cell-signalling domain shared with Delta and Serrate of Drosophila. Nature. 1994;368:150–4. doi: 10.1038/368150a0. [DOI] [PubMed] [Google Scholar]
  51. van de Peppel J, Kettelarij N, van Bakel H, Kockelkorn TT, van Leenen D, Holstege FC. Mediator expression profiling epistasis reveals a signal transduction pathway with antagonistic submodules and highly specific downstream targets. Mol Cell. 2005;19:511–22. doi: 10.1016/j.molcel.2005.06.033. [DOI] [PubMed] [Google Scholar]
  52. Wang JC, Walker A, Blackwell TK, Yamamoto KR. The Caenorhabditis elegans ortholog of TRAP240, CeTRAP240/let-19, selectively modulates gene expression and is essential for embryogenesis. J Biol Chem. 2004;279:29270–7. doi: 10.1074/jbc.M401242200. [DOI] [PubMed] [Google Scholar]
  53. Wicks SR, Yeh RT, Gish WR, Waterston RH, Plasterk RH. Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat Genet. 2001;28:160–4. doi: 10.1038/88878. [DOI] [PubMed] [Google Scholar]
  54. Wu Y, Han M. Suppression of activated Let-60 ras protein defines a role of Caenorhabditis elegans Sur-1 MAP kinase in vulval differentiation. Genes Dev. 1994;8:147–59. doi: 10.1101/gad.8.2.147. [DOI] [PubMed] [Google Scholar]
  55. Yandell MD, Edgar LG, Wood WB. Trimethylpsoralen induces small deletion mutations in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 1994;91:1381–5. doi: 10.1073/pnas.91.4.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Yoda A, Kouike H, Okano H, Sawa H. Components of the transcriptional Mediator complex are required for asymmetric cell divisions in C. elegans. Dev Biol. 2005;132:1885–1893. doi: 10.1242/dev.01776. [DOI] [PubMed] [Google Scholar]

RESOURCES